157 Spam-Free Article(s) Found
Sort:
Like
Filter:
All
Symbol Name Last Close Mkt Cap DailyStocks'
Rating
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Tuesday’s Close
NVO Novo Nordisk A/S $47.64 $114.84B Downtrend
Article Searches
Novo Nordisk's Victoza Fares Better than Sanofi's Lyxumia http://www.zacks.com/stock/news/190512/novo-nordisks-victoza-fares-better-than-sanofis-lyxumia?cid=CS-ZC-FT-190512 Sep 17, 2015 - Novo Nordisk (NVO) announced that a head-to-head study comparing Victoza to Sanofi's Lyxumia for the treatment of type II diabetes met its primary endpoint.
3M Invests for Minority Stake in StrongArm Technologies http://www.zacks.com/stock/news/190601/3m-invests-for-minority-stake-in-strongarm-technologies?cid=CS-ZC-FT-190601 Sep 18, 2015 - 3M Safety and Graphics Business Group, a part of 3M Company (MMM), recently announced a minority equity investment in StrongArm Technologies Inc., - a company that designs innovative safety products.
Novo Nordisk A/S (NVO) Q4 2015 Results - Earnings Call Webcast http://seekingalpha.com/article/3855536-novo-nordisk-s-nvo-q4-2015-results-earnings-call-webcast?source=feed_all_articles Feb 03, 2016 -
Pricing to Remain Pharma Headline Risk in 2017 http://www.zacks.com/commentary/105146/pricing-to-remain-pharma-headline-risk-in-2017?cid=CS-ZC--105146 Mar 01, 2017 - Pricing to Remain Pharma Headline Risk in 2017
Novo Nordisk's Diabetes Unit Strong; Generic Pressure Stays http://www.zacks.com/stock/news/252549/novo-nordisks-diabetes-unit-strong-generic-pressure-stays?cid=CS-ZC-FT-252549 Mar 13, 2017 - We issued an updated research report on Novo Nordisk (NVO) on Mar 9, 2017.
Orexigen Inks Commercialization Deal for Contrave, Stock Up http://www.zacks.com/stock/news/254403/orexigen-inks-commercialization-deal-for-contrave-stock-up?cid=CS-ZC-FT-254403 Mar 28, 2017 - Orexigen Therapeutics, Inc.'s (OREX) announced that it has entered into a commercialization and distributorship agreement with Italian pharmaceutical company, Bruno Farmaceutici, for its obesity drug, Contrave.
3 Best Healthcare Dividend Stocks of the 21st Century (So Far) https://www.fool.com/investing/2017/06/24/3-best-healthcare-dividend-stocks-of-the-21st-cent.aspx?source=iedfolrf0000001 Jun 24, 2017 - Perhaps surprisingly, Aetna, Novo Nordisk, and West Pharmaceutical rank as the best healthcare dividend stocks of the century.
Pharma Stock Roundup: NVS Scores with Positive Data, Shire ADHD Drug Gets FDA Nod http://www.zacks.com/stock/news/265327/pharma-stock-roundup-nvs-scores-with-positive-data-shire-adhd-drug-gets-fda-nod?cid=CS-ZC-FT-265327 Jun 23, 2017 - All major pharma stocks were up this week with companies like Novartis (NVS) presenting positive data and others gaining FDA approval.
Why You Should Add Novo Nordisk Stock to Your Portfolio http://www.zacks.com/stock/news/265294/why-you-should-add-novo-nordisk-stock-to-your-portfolio?cid=CS-ZC-FT-265294 Jun 22, 2017 - Novo Nordisk (NVO) is healthcare company and a with leadership in the global diabetes market. It looks like a great stock to buy now.
Why Red Robin Gourmet Burgers, Hertz Global Holdings, and Novo Nordisk Jumped Today https://www.fool.com/investing/2017/08/09/why-red-robin-gourmet-burgers-hertz-global-holding.aspx?source=iedfolrf0000001 Aug 09, 2017 - These stocks rose on a down day for Wall Street. Find out why.

Pages: 1234567...16

<Page 2>